Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer

ClinicalTrials.gov ID: NCT00009945

Public ClinicalTrials.gov record NCT00009945. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 5:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Clinical Trial Comparing Adjuvant Clodronate Therapy vs Placebo in Early-Stage Breast Cancer Patients Receiving Systemic Chemotherapy and/or Hormonal Therapy or No Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Clodronate may be effective in preventing the spread of cancer to the bones and other parts of the body. It is not yet known whether clodronate is more effective alone or combined with chemotherapy and /or hormonal therapy in preventing metastatic breast cancer. PURPOSE: Randomized phase III trial to determine the effectiveness of clodronate with or without chemotherapy and /or hormonal therapy in preventing metastases in women who have stage I or stage II breast cancer.

Study identification

NCT ID
NCT00009945
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
NSABP Foundation Inc
Network
Enrollment
3,323 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2001 (Type not available)
Primary completion
Mar 2011 (Actual)
Completion
Dec 2012 (Actual)
Last update posted
Dec 13, 2017

2001 – 2012

United States locations

U.S. sites
17
U.S. states
13
U.S. cities
15
Facility City State ZIP Site status
CCOP - Mayo Clinic Scottsdale Oncology Program Scottsdale Arizona 85259-5404 —
Mayo Clinic Jacksonville Florida 32224 —
MBCCOP - Hawaii Honolulu Hawaii 96813 —
CCOP - Cedar Rapids Oncology Project Cedar Rapids Iowa 52403-1206 —
Siouxland Hematology-Oncology Sioux City Iowa 51101-1733 —
Veterans Affairs Medical Center - Biloxi Biloxi Mississippi 39531-2410 —
Medcenter One Health System Bismarck North Dakota 58501-5505 —
Altru Cancer Center Grand Forks North Dakota 58201 —
CCOP - Geisinger Clinic and Medical Center Danville Pennsylvania 17822-2001 —
Rapid City Regional Hospital Rapid City South Dakota 57709 —
University of Tennessee Cancer Institute Memphis Tennessee 38103 —
Danville Radiation Therapy Center Memphis Tennessee 38104 —
Harrington Cancer Center Amarillo Texas 79106 —
Veterans Affairs Medical Center - Amarillo Amarillo Texas 79106 —
Fletcher Allen Health Care - University Health Center Campus Burlington Vermont 05401 —
MBCCOP - Massey Cancer Center Richmond Virginia 23298-0037 —
University of Washington School of Medicine Seattle Washington 98109 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00009945, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 13, 2017 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00009945 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →